Exploring Immunosuppression’s Role in ILD Treatment, with Aman Pande, MD, MS
The Evolving Role of Immunosuppression in Interstitial Lung Disease New research from the American Thoracic Society (ATS) International Conference 2025 provides a forward-looking perspective on immunosuppression therapy’s role in non-idiopathic pulmonary fibrosis (IPF) related interstitial lung disease (ILD). Highlighted by Dr. Aman Pande, this insight challenges the current understanding and management strategies. Understanding the Complexity: … Read more